Chris Senanayake Shuttle Pharmaceuticals Holdings, Inc. (SHPH) insider trading activity
Chris Senanayake is Director of Shuttle Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 2,791 shares of SHPH, which is worth approximately $1,814. The most recent transaction as insider was on Dec 29, 2022, when has been sold 1,626 shares (Common Stock) at a price of $1.6 per share, resulting in proceeds of $2,601. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.79K
0%
3M change
0%
12M change
Total Value Held
$1,814
CS
Chris Senanayake
Director
Gaithersburg, MD